Wedbush analyst Moshe Katri lowered the firm’s price target on Accenture to $350 from $400 and keeps an Outperform rating on the shares after the company announced multiple leadership changes, including a CFO transition. This, in the firm’s view, points to Accenture’s fine-tweaking its executive team as a response to ongoing changes in sector dynamics, including GenAI’s expected disruptive impact on overall business models as well as macro-related visibility challenges.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACN:
- Accenture Announces Major Leadership Restructuring and Roles Expansion
- Accenture price target lowered to $294 from $350 at TD Cowen
- TSA awards Accenture blanket purchase deal with $170M ceiling value
- Bath & Body Works collaborates with Accenture
- Accenture price target lowered to $275 from $340 at Jefferies